{"name": "Actimis Pharmaceuticals",
 "permalink": "actimis-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/actimis-pharmaceuticals",
 "homepage_url": "http://www.actimis.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "(858) 458-1890",
 "description": "Small molecule therapeutics",
 "created_at": "Sat Jun 06 15:18:35 UTC 2009",
 "updated_at": "Sat Aug 28 13:32:03 UTC 2010",
 "overview": "\u003Cp\u003EActimis Pharmaceuticals, Inc., is a start-up biopharmaceutical company focused on the development of small molecule therapeutics for respiratory and inflammatory disorders. Actimis was created as a spin-off from the respiratory diseases therapeutic research portfolio of Bayer Healthcare AG. The spin-off was founded by Dr. Kevin Bacon and has received venture financing from a syndicate lead by Sanderling Ventures of San Mateo, California and Mitsui \u0026amp; Co Venture Partners of New York. Dr. Bacon was most recently Vice President and Global Head of Respiratory diseases research at Bayer Yakuhin Ltd., Japan where the programs were initiated.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0004/7125/47125v1-max-150x150.jpg"],
     [[230,
       70],
      "assets/images/resized/0004/7125/47125v1-max-250x250.jpg"],
     [[230,
       70],
      "assets/images/resized/0004/7125/47125v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman and Acting CEO",
    "person":
     {"first_name": "Peter",
      "last_name": "McWilliams, Ph.D.",
      "permalink": "peter-mcwilliams-ph-d",
      "image": null}},
   {"is_past": false,
    "title": "Founder, CSO and Head of Research \u0026 Development ",
    "person":
     {"first_name": "Kevin",
      "last_name": "B. Bacon",
      "permalink": "kevin-b-bacon",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Taro",
      "last_name": "Inaba",
      "permalink": "taro-inaba-2",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Fred",
      "last_name": "Middleton",
      "permalink": "fred-middleton",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0004/7127/47127v1-max-150x150.jpg"],
          [[150,
            225],
           "assets/images/resized/0004/7127/47127v1-max-250x250.jpg"],
          [[150,
            225],
           "assets/images/resized/0004/7127/47127v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$15.6M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "Capital Funding Report",
    "raised_amount": 9600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 6,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sanderling Ventures",
         "permalink": "sanderling-ventures",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0004/4787/44787v2-max-150x150.jpg"],
             [[250,
               86],
              "assets/images/resized/0004/4787/44787v2-max-250x250.jpg"],
             [[304,
               105],
              "assets/images/resized/0004/4787/44787v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://actimis.com/seriesa.htm",
    "source_description": "ACTIMIS PHARMACEUTICALS, COMPLETES $6 MILLION SERIES A FINANCING",
    "raised_amount": 6000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 4,
    "funded_day": 28,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sanderling Ventures",
         "permalink": "sanderling-ventures",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0004/4787/44787v2-max-150x150.jpg"],
             [[250,
               86],
              "assets/images/resized/0004/4787/44787v2-max-250x250.jpg"],
             [[304,
               105],
              "assets/images/resized/0004/4787/44787v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mitsui Ventures",
         "permalink": "mitsui-ventures",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0002/0633/20633v1-max-150x150.png"],
             [[250,
               31],
              "assets/images/resized/0002/0633/20633v1-max-250x250.png"],
             [[250,
               31],
              "assets/images/resized/0002/0633/20633v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 515000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.boehringer-ingelheim.com/corporate/news/press_releases/detail.asp?ID=5614",
   "source_description": "Boehringer Ingelheim to acquire Actimis Pharmaceuticals ",
   "acquired_year": 2008,
   "acquired_month": 6,
   "acquired_day": 17,
   "acquiring_company":
    {"name": "Boehringer Ingelheim",
     "permalink": "boehringer-ingelheim",
     "image":
      {"available_sizes":
        [[[135,
           40],
          "assets/images/resized/0005/9765/59765v1-max-150x150.png"],
         [[135,
           40],
          "assets/images/resized/0005/9765/59765v1-max-250x250.png"],
         [[135,
           40],
          "assets/images/resized/0005/9765/59765v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "10835 Road To The Cure ",
    "address2": "Suite 200",
    "zip_code": "92121",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 32.902232,
    "longitude": -117.236374}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0004/7124/47124v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0004/7124/47124v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0004/7124/47124v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}